நோயாளி கண்காணிப்பு அமை க்கு ஏற்றம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In Severe COVID-19 Patients, Arthritis Drug Shows No Response
by Pooja Shete on 
January 24, 2021 at 1:00 AM
The findings of this trial are published in the journal
The BMJ
The trial was stopped early as there was an increased number of deaths in patients receiving tocilizumab.
The result of this study contradicts the previous observational studies that suggested possible benefits of tocilizumab. Observational studies are limited as they have a high risk of other unknown factors which can influence the study.
Tocilizumab acts by blocking interleukin 6, a specific part of the immune system that can go into overdrive in some COVID-19 patients. This can help reduce the body s inflammatory response to the virus and avoid some of the more dire consequences of the disease. However, its effects are not well defined. ....

United Kingdom , Toxicityknee Replacementreactive Arthritisdrugs , United Kingdom National Early Warning Risk Score , All You Need To Know About , Kingdom Becomes First , Use Digital Ledgers , Evaluates Prediction , Patient Monitoring Set To Boom , Health Care , Infectious Arthritis , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது கிஂக்டம் தேசிய ஆரம்ப எச்சரிக்கை ஆபத்து மதிப்பெண் , கிஂக்டம் ஆகிறது முதல் , பயன்பாடு டிஜிட்டல் லெட்ஜர்கள் , நோயாளி கண்காணிப்பு அமை க்கு ஏற்றம் , ஆரோக்கியம் பராமரிப்பு , தொற்று கீல்வாதம் ,